Skip to main content
Top
Published in: Quality of Life Research 12/2019

Open Access 01-12-2019 | Systemic Sclerosis

Factors associated with quality of life in systemic sclerosis: a cross-sectional study

Authors: Matylda Sierakowska, Halina Doroszkiewicz, Justyna Sierakowska, Marzena Olesińska, Agnieszka Grabowska-Jodkowska, Marek Brzosko, Piotr Leszczyński, Katarzyna Pawlak-Buś, Bogdan Batko, Piotr Wiland, Maria Majdan, Małgorzata Bykowska-Sochacka, Wojciech Romanowski, Aleksandra Zon-Giebel, Sławomir Jeka, Mwidimi Ndosi

Published in: Quality of Life Research | Issue 12/2019

Login to get access

Abstract

Introduction

Systemic sclerosis (SSc) is a connective tissue disease characterized by progressive fibrosis of the skin and internal organs, leading to their failure and disturbances in the morphology and function of blood vessels. The disease affects people in different ways, and identifying how the difficulties and limitations are related to quality of life may contribute to designing helpful interventions. The aim of this study was to identify factors associated with quality of life in people with SSc.

Methods

This was a cross-sectional study conducted in 11 rheumatic centres in Poland. Patients diagnosed with SSc were included. Quality of life was measured using the SSc Quality of Life Questionnaire (SScQoL). The following candidate factors were entered in preliminary multivariable analysis: age, place of residence, marital status, occupational status, disease type, disease duration, pain, fatigue, intestinal problems, breathing problems, Raynaud’s symptoms, finger ulcerations, disease severity, functional disability, anxiety and depression. Factors that achieved statistical significance at the 10% level were then entered into a final multivariable model. Factors achieving statistical significance at the 5% level in the final model were considered to be associated with quality of life in SSc.

Results

In total, 231 participants were included. Mean age (SD) was 55.82 (12.55) years, disease duration 8.39 (8.18) years and 198 (85.7%) were women. Factors associated with quality of life in SSc were functional disability (β = 2.854, p < 0.001) and anxiety (β = 0.404, p < 0.001). This model with two factors (functional disability and anxiety) explained 56.7% of the variance in patients with diffuse SSc and 73.2% in those with localized SSc.

Conclusions

Functional disability and anxiety are significantly associated with quality of life in SSc. Interventions aimed at improving either of these factors may contribute towards improving the quality of life of people with SSc.
Appendix
Available only for authorised users
Literature
1.
go back to reference Kulikowski, K. (2014). Quality of life in the context of psychology and medicine. Reumatologia,52(3), 200–206.CrossRef Kulikowski, K. (2014). Quality of life in the context of psychology and medicine. Reumatologia,52(3), 200–206.CrossRef
2.
go back to reference Sierakowski, S., & Sierakowska, M. (2014). Systemic sclerosis. In I. Zimmermann-Górska (Ed.), Advances in clinical rheumatology (pp. 189–212). Warszawa: Wydawnictwo Lekarskie PZWL. Sierakowski, S., & Sierakowska, M. (2014). Systemic sclerosis. In I. Zimmermann-Górska (Ed.), Advances in clinical rheumatology (pp. 189–212). Warszawa: Wydawnictwo Lekarskie PZWL.
3.
go back to reference Sierakowski, S., & Sierakowska, M. (2016). Systemic sclerosis. In P. Gajewski (Ed.), Interstitial Szczeklika 2016, Handbook of internal diseases (pp. 1955–1963). Kraków: Medycyna Praktyczna. Sierakowski, S., & Sierakowska, M. (2016). Systemic sclerosis. In P. Gajewski (Ed.), Interstitial Szczeklika 2016, Handbook of internal diseases (pp. 1955–1963). Kraków: Medycyna Praktyczna.
4.
go back to reference Clements, P. J., & Frust, D. F. (2004). Systemic sclerosis (2nd ed.). Philadelphia: Lipincott Williams & Wilkins. Clements, P. J., & Frust, D. F. (2004). Systemic sclerosis (2nd ed.). Philadelphia: Lipincott Williams & Wilkins.
5.
go back to reference Ranque, B., & Mouthon, L. (2010). Geoepidemiology of systemic sclerosis. Autoimmunity Reviews,9, A311–A318.CrossRef Ranque, B., & Mouthon, L. (2010). Geoepidemiology of systemic sclerosis. Autoimmunity Reviews,9, A311–A318.CrossRef
6.
go back to reference Kowal-Bielecka, O., Fransen, J., Avouac, J., Becker, M., Kulak, A., Allanore, Y., et al. (2015). Update of EULAR recommendations for the treatment of systemic sclerosis. Annals of the Rheumatic Diseases,74(Suppl. 2), 90. Kowal-Bielecka, O., Fransen, J., Avouac, J., Becker, M., Kulak, A., Allanore, Y., et al. (2015). Update of EULAR recommendations for the treatment of systemic sclerosis. Annals of the Rheumatic Diseases,74(Suppl. 2), 90.
7.
go back to reference Sierakowska, M., & Rudzik, T. (2017). Nursing care for people with rheumatic diseases. In D. Talarska & D. Zozulińska-Ziółkiewicz (Eds.), Nursing internship (pp. 335–373). Warszawa: Wydawnictwo Lekarskie PZWL. Sierakowska, M., & Rudzik, T. (2017). Nursing care for people with rheumatic diseases. In D. Talarska & D. Zozulińska-Ziółkiewicz (Eds.), Nursing internship (pp. 335–373). Warszawa: Wydawnictwo Lekarskie PZWL.
8.
go back to reference Kuryłek, A., Steuden, S., Bogaczewicz, J., Sysa-Jędrzejowska, A., & Woźniack, A. (2008). Determinants of quality of life in patients with systemic sclerosis. Reumatologia,46(2), 84–90. Kuryłek, A., Steuden, S., Bogaczewicz, J., Sysa-Jędrzejowska, A., & Woźniack, A. (2008). Determinants of quality of life in patients with systemic sclerosis. Reumatologia,46(2), 84–90.
9.
go back to reference Danieli, E., Airò, P., Bettoni, L., Cinquini, M., Antonioli, C. M., Cavazzana, I., et al. (2005). Health-related quality of life measured by the Short Form 36 (SF-36) in systemic sclerosis: Correlations with indexes of disease activity and severity, disability, and depressive symptoms. Clinical Rheumatology,24(1), 48–54.CrossRef Danieli, E., Airò, P., Bettoni, L., Cinquini, M., Antonioli, C. M., Cavazzana, I., et al. (2005). Health-related quality of life measured by the Short Form 36 (SF-36) in systemic sclerosis: Correlations with indexes of disease activity and severity, disability, and depressive symptoms. Clinical Rheumatology,24(1), 48–54.CrossRef
10.
go back to reference Hyphantis, T. N., Tsifetaki, N., Pappa, C., Voulgari, P. V., Siafaka, V., Bai, M., et al. (2007). Clinical features and personality traits associated with psychological distress in systemic sclerosis patients. Journal of Psychosomatic Research,62(1), 47–56.CrossRef Hyphantis, T. N., Tsifetaki, N., Pappa, C., Voulgari, P. V., Siafaka, V., Bai, M., et al. (2007). Clinical features and personality traits associated with psychological distress in systemic sclerosis patients. Journal of Psychosomatic Research,62(1), 47–56.CrossRef
11.
go back to reference Schipper, H., Clinch, J., & Powell, V. (1996). Quality of life studies: Definitions and conceptual issues. In B. Spilker (Ed.), Quality of life and pharmacoeconomics in clinical trials (pp. 11–24). Philadelphia, PA: Lippincott-Raven. Schipper, H., Clinch, J., & Powell, V. (1996). Quality of life studies: Definitions and conceptual issues. In B. Spilker (Ed.), Quality of life and pharmacoeconomics in clinical trials (pp. 11–24). Philadelphia, PA: Lippincott-Raven.
12.
go back to reference van den Hoogen, F., Khanna, D., Fransen, J., Johnson, S. R., Baron, M., Tyndall, A., et al. (2013). 2013 classification criteria for systemic sclerosis: An American college of rheumatology/European league against rheumatism collaborative initiative. Annals of the Rheumatic Diseases,72(11), 1747–1755.CrossRef van den Hoogen, F., Khanna, D., Fransen, J., Johnson, S. R., Baron, M., Tyndall, A., et al. (2013). 2013 classification criteria for systemic sclerosis: An American college of rheumatology/European league against rheumatism collaborative initiative. Annals of the Rheumatic Diseases,72(11), 1747–1755.CrossRef
13.
go back to reference Ndosi, M., Alcacer-Pitarch, B., Allanore, Y., Del Galdo, F., Frerix, M., Díaz- García, S., et al. (2018). Common measure of quality of life for people with systemic sclerosis across seven European countries: A cross-sectional study. Annals of the Rheumatic Diseases,77(7), 1032–1038.CrossRef Ndosi, M., Alcacer-Pitarch, B., Allanore, Y., Del Galdo, F., Frerix, M., Díaz- García, S., et al. (2018). Common measure of quality of life for people with systemic sclerosis across seven European countries: A cross-sectional study. Annals of the Rheumatic Diseases,77(7), 1032–1038.CrossRef
14.
go back to reference Fries, J. F., & Spitz, P. (1980). Measurement of patient outcome in arthritis. Arthritis & Rheumatology,23(2), 137–145.CrossRef Fries, J. F., & Spitz, P. (1980). Measurement of patient outcome in arthritis. Arthritis & Rheumatology,23(2), 137–145.CrossRef
15.
go back to reference Cole, J. C., Khanna, D., Clements, P. J., Seibold, J. R., Tashkin, D. P., Paulus, H. E., et al. (2006). Single-factor scoring validation for the Health Assessment Questionnaire-Disability Index (HAQ-DI) in patients with systemic sclerosis and comparison with early rheumatoid arthritis patients. Quality of Life Research,15(8), 1383–1394.CrossRef Cole, J. C., Khanna, D., Clements, P. J., Seibold, J. R., Tashkin, D. P., Paulus, H. E., et al. (2006). Single-factor scoring validation for the Health Assessment Questionnaire-Disability Index (HAQ-DI) in patients with systemic sclerosis and comparison with early rheumatoid arthritis patients. Quality of Life Research,15(8), 1383–1394.CrossRef
16.
go back to reference Wiland, P. (2008). Monitoring of patient status in rheumatic diseases. Wrocław: Górnicki Wydawnictwo Medyczne. Wiland, P. (2008). Monitoring of patient status in rheumatic diseases. Wrocław: Górnicki Wydawnictwo Medyczne.
17.
go back to reference Zigmond, A. S., & Snaith, R. P. (1983). The Hospital Anxiety and Depression Scale. Acta Psychiatrica Scandinavica,67(6), 361–370.CrossRef Zigmond, A. S., & Snaith, R. P. (1983). The Hospital Anxiety and Depression Scale. Acta Psychiatrica Scandinavica,67(6), 361–370.CrossRef
18.
go back to reference Sandqvist, G., & Hesselstrand, R. (2019). Validity of the Swedish version of the systemic sclerosis quality of life questionnaire (SSCQoL): A novel measure of quality of life for patients with systemic sclerosis. Annals of the Rheumatic Diseases,78(6), 855–857.CrossRef Sandqvist, G., & Hesselstrand, R. (2019). Validity of the Swedish version of the systemic sclerosis quality of life questionnaire (SSCQoL): A novel measure of quality of life for patients with systemic sclerosis. Annals of the Rheumatic Diseases,78(6), 855–857.CrossRef
19.
go back to reference Sandqvist, G., Eklund, M., Akesson, A., & Nordenskiöld, U. (2004). Daily activities and hand function in women with scleroderma. Scandinavian Journal of Rheumatology,33(2), 102–107.CrossRef Sandqvist, G., Eklund, M., Akesson, A., & Nordenskiöld, U. (2004). Daily activities and hand function in women with scleroderma. Scandinavian Journal of Rheumatology,33(2), 102–107.CrossRef
20.
go back to reference Poole, J. L., Macintyre, N. J., & Deboer, H. N. (2013). Evidence-based management of hand and mouth disability in a woman living with diffuse systemic sclerosis (scleroderma). Physiotherapy Canada,65(4), 317–320.CrossRef Poole, J. L., Macintyre, N. J., & Deboer, H. N. (2013). Evidence-based management of hand and mouth disability in a woman living with diffuse systemic sclerosis (scleroderma). Physiotherapy Canada,65(4), 317–320.CrossRef
21.
go back to reference Mendelson, C., & Polle, J. L. (2007). Become your own advocate: Advice from women living with scleroderma. Disability and Rehabilitation,29(19), 1492–1501.CrossRef Mendelson, C., & Polle, J. L. (2007). Become your own advocate: Advice from women living with scleroderma. Disability and Rehabilitation,29(19), 1492–1501.CrossRef
22.
go back to reference Legendre, C., Allanore, Y., Ferrand, I., et al. (2005). Evaluation of depression and anxiety in patients with systemic sclerosis. Joint Bone Spine,72(5), 408–411.CrossRef Legendre, C., Allanore, Y., Ferrand, I., et al. (2005). Evaluation of depression and anxiety in patients with systemic sclerosis. Joint Bone Spine,72(5), 408–411.CrossRef
23.
go back to reference Sierakowska, M., Sierakowski, S., Sierakowska, J., Krajewska-Kułak, E., & Ndosi, M. (2018). Pain, fatigue and functional disability are associated with higher educational needs in systemic sclerosis: A cross-sectional study. Rheumatology International,38(8), 1471–1478.CrossRef Sierakowska, M., Sierakowski, S., Sierakowska, J., Krajewska-Kułak, E., & Ndosi, M. (2018). Pain, fatigue and functional disability are associated with higher educational needs in systemic sclerosis: A cross-sectional study. Rheumatology International,38(8), 1471–1478.CrossRef
24.
go back to reference Sandusky, S. B., McGuire, L., Smith, M. T., Wigley, F. M., & Haythornthwaite, J. A. (2009). Fatigue: An overlooked determinant of physical function in scleroderma. Rheumatology,48(2), 165–169.CrossRef Sandusky, S. B., McGuire, L., Smith, M. T., Wigley, F. M., & Haythornthwaite, J. A. (2009). Fatigue: An overlooked determinant of physical function in scleroderma. Rheumatology,48(2), 165–169.CrossRef
25.
go back to reference Hudson, M., Steele, R., Lu, Y., Thombs, B. D., Canadian Scleroderma Research Group, & Baron, M. (2009). Work disability in systemic sclerosis. Journal of Rheumatology,36(11), 2481–2486.CrossRef Hudson, M., Steele, R., Lu, Y., Thombs, B. D., Canadian Scleroderma Research Group, & Baron, M. (2009). Work disability in systemic sclerosis. Journal of Rheumatology,36(11), 2481–2486.CrossRef
26.
go back to reference Strickland, G., Pauling, J., Cavill, C., & McHugh, N. (2012). Predictors of health-related quality of life and fatigue in systemic sclerosis: Evaluation of the EuroQol-5D and FACIT-F assessment tools. Clinical Rheumatology,31(8), 1215–1222.CrossRef Strickland, G., Pauling, J., Cavill, C., & McHugh, N. (2012). Predictors of health-related quality of life and fatigue in systemic sclerosis: Evaluation of the EuroQol-5D and FACIT-F assessment tools. Clinical Rheumatology,31(8), 1215–1222.CrossRef
27.
go back to reference Bassel, M., Hudson, M., Taillefer, S. S., Schieir, O., Baron, M., & Thombs, B. D. (2011). Frequency and impact of symptoms experienced by patients with systemic sclerosis: Results from a Canadian National Survey. Rheumatology (Oxford),50(4), 762–767.CrossRef Bassel, M., Hudson, M., Taillefer, S. S., Schieir, O., Baron, M., & Thombs, B. D. (2011). Frequency and impact of symptoms experienced by patients with systemic sclerosis: Results from a Canadian National Survey. Rheumatology (Oxford),50(4), 762–767.CrossRef
28.
go back to reference van Lankveld, W. G., Vonk, M. C., Teunissen, H., & van den Hoogen, F. H. (2007). Appearance self-esteem in systemic sclerosis: Subjective experience of skin deformity and its relationship with physician-assessed skin involvement, disease status and psychological variables. Rheumatology (Oxford),46(5), 872–876.CrossRef van Lankveld, W. G., Vonk, M. C., Teunissen, H., & van den Hoogen, F. H. (2007). Appearance self-esteem in systemic sclerosis: Subjective experience of skin deformity and its relationship with physician-assessed skin involvement, disease status and psychological variables. Rheumatology (Oxford),46(5), 872–876.CrossRef
29.
go back to reference Malcarne, V. (2004). Psychological adjustment in systemic sclerosis. In P. J. Clements & D. E. Furst (Eds.), Systemic sclerosis (pp. 331–350). Philadelphia: Lippincott. Malcarne, V. (2004). Psychological adjustment in systemic sclerosis. In P. J. Clements & D. E. Furst (Eds.), Systemic sclerosis (pp. 331–350). Philadelphia: Lippincott.
30.
go back to reference Schnitzer, M., Hudson, M., Baron, M., Steele, R., & Canadian Scleroderma Research Group. (2011). Disability in systemic sclerosis—A longitudinal observational study. Journal of Rheumatology,38(4), 685–692.CrossRef Schnitzer, M., Hudson, M., Baron, M., Steele, R., & Canadian Scleroderma Research Group. (2011). Disability in systemic sclerosis—A longitudinal observational study. Journal of Rheumatology,38(4), 685–692.CrossRef
31.
go back to reference Lumetti, F., Barone, L., Alfieri, C., Silva, M., Serra, V., et al. (2015). Quality of life and functional disability in patients with interstitial lung disease related to Systemic Sclerosis. Acta BioMedica,86(2), 142–148.PubMed Lumetti, F., Barone, L., Alfieri, C., Silva, M., Serra, V., et al. (2015). Quality of life and functional disability in patients with interstitial lung disease related to Systemic Sclerosis. Acta BioMedica,86(2), 142–148.PubMed
32.
go back to reference Sheehy, C., Murphy, E., & Barry, M. (2006). Depression in rheumatoid arthritis underscoring the problem. Rheumatology (Oxford),45(11), 1325–1327.CrossRef Sheehy, C., Murphy, E., & Barry, M. (2006). Depression in rheumatoid arthritis underscoring the problem. Rheumatology (Oxford),45(11), 1325–1327.CrossRef
33.
go back to reference Brezinova, P., Englbrecht, M., Lovric, S., et al. (2013). Coping strategies and depressiveness in primary systemic vasculitis with is their impact on health-related quality of life? Rheumatology (Oxford),52(10), 1856–1864.CrossRef Brezinova, P., Englbrecht, M., Lovric, S., et al. (2013). Coping strategies and depressiveness in primary systemic vasculitis with is their impact on health-related quality of life? Rheumatology (Oxford),52(10), 1856–1864.CrossRef
34.
go back to reference Benrud-Larson, L. M., Haythornthwaite, J. A., Heinberg, L. J., Boling, C., Reed, J., et al. (2002). The impact of pain and symptoms of depression in scleroderma. Pain,95(3), 267–275.CrossRef Benrud-Larson, L. M., Haythornthwaite, J. A., Heinberg, L. J., Boling, C., Reed, J., et al. (2002). The impact of pain and symptoms of depression in scleroderma. Pain,95(3), 267–275.CrossRef
35.
go back to reference Beretta, L., Astori, S., Ferrario, E., Caronni, M., Raimondi, M., & Scorza, R. (2006). Determinants of depression in 111 Italian patients with systemic sclerosis. Reumatismo,58(3), 219–225.PubMed Beretta, L., Astori, S., Ferrario, E., Caronni, M., Raimondi, M., & Scorza, R. (2006). Determinants of depression in 111 Italian patients with systemic sclerosis. Reumatismo,58(3), 219–225.PubMed
36.
go back to reference Alonso, J., Ferrer, M., Gandek, B., Ware, J. E., Jr., Aaronson, N. K., Mosconi, P., et al. (2004). Health related quality of life associated with chronic conditions in eight countries: Results from the International Quality of Life Assessment (IQOLA) Project. Quality of Life Research,13(2), 283–298.CrossRef Alonso, J., Ferrer, M., Gandek, B., Ware, J. E., Jr., Aaronson, N. K., Mosconi, P., et al. (2004). Health related quality of life associated with chronic conditions in eight countries: Results from the International Quality of Life Assessment (IQOLA) Project. Quality of Life Research,13(2), 283–298.CrossRef
37.
go back to reference Leon, J., Jover, J. A., Loza, E., Zunzunegui, M. V., Lajas, C., et al. (2013). Health-related quality of life as a main determinant of access to rheumatologic care. Rheumatology International,33, 1797–1804.CrossRef Leon, J., Jover, J. A., Loza, E., Zunzunegui, M. V., Lajas, C., et al. (2013). Health-related quality of life as a main determinant of access to rheumatologic care. Rheumatology International,33, 1797–1804.CrossRef
38.
go back to reference Sierakowska, M., Sierakowski, S., Sierakowska, J., Horton, M., & Ndosi, M. (2015). Developing the Polish Educational Needs Assessment Tool (Pol-ENAT) in rheumatoid arthritis and systemic sclerosis: A cross-cultural validation study using Rasch analysis. Quality of Life Research,24(3), 721–733.CrossRef Sierakowska, M., Sierakowski, S., Sierakowska, J., Horton, M., & Ndosi, M. (2015). Developing the Polish Educational Needs Assessment Tool (Pol-ENAT) in rheumatoid arthritis and systemic sclerosis: A cross-cultural validation study using Rasch analysis. Quality of Life Research,24(3), 721–733.CrossRef
39.
go back to reference Ndosi, M., Bremander, A., Hamnes, B., Horton, M., Kukkurainen, M. L., Machado, P., et al. (2014). Validation of the educational needs assessment tool as a generic instrument for rheumatic diseases in seven European countries. Annals of the Rheumatic Diseases,73(12), 2122–2129.CrossRef Ndosi, M., Bremander, A., Hamnes, B., Horton, M., Kukkurainen, M. L., Machado, P., et al. (2014). Validation of the educational needs assessment tool as a generic instrument for rheumatic diseases in seven European countries. Annals of the Rheumatic Diseases,73(12), 2122–2129.CrossRef
40.
go back to reference Kwakkenbos, L., Jewett, L. R., Baron, M., Bartlett, S. J., Furst, D., et al. (2013). The Scleroderma Patient-centered Intervention Network (SPIN) Cohort: Protocol for a cohort multiple randomized controlled trial (RCT) design to support trials of psychosocial and rehabilitation interventions in a rare disease con-text. British Medical Journal Open,3, e003563. Kwakkenbos, L., Jewett, L. R., Baron, M., Bartlett, S. J., Furst, D., et al. (2013). The Scleroderma Patient-centered Intervention Network (SPIN) Cohort: Protocol for a cohort multiple randomized controlled trial (RCT) design to support trials of psychosocial and rehabilitation interventions in a rare disease con-text. British Medical Journal Open,3, e003563.
Metadata
Title
Factors associated with quality of life in systemic sclerosis: a cross-sectional study
Authors
Matylda Sierakowska
Halina Doroszkiewicz
Justyna Sierakowska
Marzena Olesińska
Agnieszka Grabowska-Jodkowska
Marek Brzosko
Piotr Leszczyński
Katarzyna Pawlak-Buś
Bogdan Batko
Piotr Wiland
Maria Majdan
Małgorzata Bykowska-Sochacka
Wojciech Romanowski
Aleksandra Zon-Giebel
Sławomir Jeka
Mwidimi Ndosi
Publication date
01-12-2019
Publisher
Springer International Publishing
Published in
Quality of Life Research / Issue 12/2019
Print ISSN: 0962-9343
Electronic ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-019-02284-9

Other articles of this Issue 12/2019

Quality of Life Research 12/2019 Go to the issue